உலகளாவிய ஆரோக்கியம் அறிவியல் நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய ஆரோக்கியம் அறிவியல் நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய ஆரோக்கியம் அறிவியல் நிதி Today - Breaking & Trending Today

Eyevensys Raises $12M in Series B+ Funding

Eyevensys Raises $12M in Series B+ Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , France General , South Korea , Pureos Bioventures , Patricia Zilliox , Inserm Transfert Initiative , Global Health Sciences Fund , Innobio Fund , Boehringer Ingelheim Venture Fund , Korea Investment , Electrotransfection System , Global Health Sciences , ஒன்றுபட்டது கிஂக்டம் , தெற்கு கொரியா , உலகளாவிய ஆரோக்கியம் அறிவியல் நிதி , போஹெரிங்கர் இஂகல்‌ஹைம் துணிகர நிதி , கொரியா முதலீடு , உலகளாவிய ஆரோக்கியம் அறிவியல் ,

Eyevensys Raises $12M in a Series B Plus Funding Round

Eyevensys Raises $12M in a Series B Plus Funding Round
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Soult Ukpyolsi , South Korea , France General , United States , United Kingdom , Wedbush Pacgrow , Francine Behar Cohen , Sangwoo Lee , Pureos Bioventures , Patricia Zilliox , Jeanene Timberlake , Global Health Sciences Fund , Inserm Transfert Initiative , European Medicines Agency , Innobio Fund , Boehringer Ingelheim Venture Fund , Seriesb Plus , Investment Partners , Electrotransfection System , Korea Investment Partners , Managing Director , Global Health Sciences , Media Relations , Business Wire , தெற்கு கொரியா , ஒன்றுபட்டது மாநிலங்களில் ,

Global Health Sciences Fund (Quark Venture LP and GF Securities) Participates in $25 Million Financing for EyeYon Medical's EndoArt® Clinical Trials Across Three Continents

Global Health Sciences Fund (Quark Venture LP and GF Securities) Participates in $25 Million Financing for EyeYon Medical’s EndoArt® Clinical Trials Across Three Continents
March 15, 2021 13:05 ET
| Source:
Quark Venture LP
Quark Venture LP
Vancouver, British Columbia, CANADA
VANCOUVER, British Columbia, March 15, 2021 (GLOBE NEWSWIRE) Quark Venture LP (Quark) and GF Securities participated in the $25 million financing of EyeYon Medical, to advance its EndoArt
® clinical trials. This investment, made through the Global Health Sciences (GHS) fund, was led by a global ophthalmology industry leader and CRCP alongside new and existing shareholders BPC, Diamond BioFund, Rimonci, Pontifax and Triventures.
Quark Venture’s investment in EyeYon Medical will enable the corneal healing solutions provider to accelerate its EndoArt ....

United States , United Kingdom , British Columbia , Nahum Ferera , Neena Kadaba , Kaley Wilson , Global Health Sciences Fund , Global Health Sciences , Eyeyon Medical , Diamond Biofund , Quark Venture , Eyeyon Medical Board , Health Sciences , Yon Medical , Artificial Endothelial Layer , Quark Venture Lp , Venture Capital , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , நீன கடபா , காலே வில்சன் , உலகளாவிய ஆரோக்கியம் அறிவியல் நிதி , உலகளாவிய ஆரோக்கியம் அறிவியல் , குவார்க் துணிகர , ஆரோக்கியம் அறிவியல் ,

Eyevensys Named to French Tech 120 Program

Press release content from Business Wire. The AP news staff was not involved in its creation.
Eyevensys Named to French Tech 120 Program
February 15, 2021 GMT
PARIS & CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 15, 2021
Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announced it has been accepted into the French Tech 120 program for 2021.
This government-backed program, run by La French Tech, offers support for 120 French startups considered late-stage and in a hypergrowth phase. Participating companies benefit from a variety of initiatives designed to support the needs of companies in this stage, such as unlimited access to government, public and ministry services, as well as tailored services from partner agencies. Participants will also benefit from collaboration with the French Tech 120 community, and a needs analysis that will help shape future regulations. ....

United Kingdom , France General , United States , Francine Behar Cohen , Pureos Bioventures , Patricia Zilliox , Marion Janic , Global Health Sciences Fund , Inserm Transfert Initiative , European Medicines Agency , Innobio Fund , Boehringer Ingelheim Venture Fund , French Tech , Electrotransfection System , Chief Innovation Officer , Therapy Showcase , Retinitis Pigmentosa , Electro Study , Global Health Sciences , Media Relations Contact , Business Wire , Products And Services , Western Europe , Product Testing , Diagnosis And Treatment , Health Care Industry ,